11 – 15 February 2017 Tue, 14 February
Davos 2
08:00 – 09:30 Session 1: Atrial Fibrillation
Chairs: A. J. Camm, London and F. Duru, Zurich
08:00 New ESC Guidelines on atrial fibrillation A. J. Camm, London
08:22 Catheter ablation of AF: State of the art in 2017 H. Calkins, Baltimore
08:44 FIRE and ICE Trial and beyond: Which ablation is better than drugs? K. H. Kuck, Hamburg
09:06 Anticoagulation in AF 2017: Which drugs for which patient? J. Steffel, Zurich
09:30 – 10:00 Coffee

Davos 2
10:00 – 11:30 Session 2: Cardiomyopathies
Chairs: H. Calkins, Baltimore and O. A. Smiseth, Oslo
10:00 Imaging of cardiomyopathies F. C. Tanner, Zurich
10:22 The clinical spectrum of cardiomyopathies P. Elliott, London
10:44 Genetic testing as guide to management G. S. Pitt, New York
11:06 Update on arrythmogenic cardiomyopathies A. Saguner, Zurich
Seehorn
12:00 – 13:15 Lunch / Satellite Symposium AstraZeneca (a lunch bag will be offered)
Chair: T. F. Lüscher, Zurich

Long-term dual antiplatelet therapy – Who, why, for how long?

12:00 Introduction by the chairperson
12:05 Risk perception post-MI: Is it the stent or the patients we need to protect? T. F. Lüscher, Zurich
12:35 Long-term DAPT post-MI? – What the data suggest to do E. Giannitsis, Heidelberg
13:05 Discussion and take-home message
Schwarzhorn
12:00 – 13:15 Lunch / Satellite Symposium Daiichi-Sankyo (a lunch bag will be offered)
Chair: A. J. Camm, London

Meeting the challenges in atrial fibrillation: the role of edoxaban

12:00 Introduction A. J. Camm, London
12:05 What does edoxaban add to the management of patients with atrial fibrillation? A. J. Camm, London
12:20 Balancing efficacy, safety and convenience of edoxaban J. Steffel, Zurich
12:35 Translating trial results into clinical practice F. Mach, Geneva
12:50 Podium discussion
13:10 Summary and take-home message A. J. Camm, London
Davos 2
13:30 – 15:00 Session 3: Mitral Valve Disease
Chairs: D. Milicic, Zagreb and F. Ruschitzka, Zurich
13:30 The role of imaging in patient selection J. J. Bax, Leiden
13:52 Mitral valve repair: from surgery to percutaneous interventions F. Maisano, Zurich
14:14 When is it too late to intervene in patients with MR? A. Vahanian, Paris
14:36 Heart Failure and mitral valve disease A. Flammer, Zurich
15:00 – 15:30 Coffee

Foyer
15:00 – 16:30 Poster Session: Heart Failure, CAD, ACS
Chair: C. M. Matter, Zurich
Schwarzhorn
15:30 – 16:30 Meet the Expert Session - Cardiomyopathies
Moderators: H. Calkins, Baltimore and P. Elliott, London
Cases: C. Gruner, Zurich and D. Akdis, Zurich

Challenging cases in cardiomyopathies

15:30 Case 1: A patient with hypertrophic cardiomyopathy and fibrosis without risk for SCD C. Gruner, Zurich
16:00 Case 2: A patient with ARVC D. Akdis, Zurich
Wisshorn
15:30 – 16:30 Meet the Expert Session - Ultrasound-guided interventions (Live in-a-box)
Cases: R. Binder, Zurich and M. Zuber, Zurich
Seehorn
15:30 – 16:30 Meet the Expert Session - Ventricular tachycardias
Moderators: A. J. Camm, London and C. Brunckhorst, Zurich
Cases: L. Haegeli, Zurich and S. A. Müller-Burri, Zurich
Davos 1
15:30 – 16:30 Meet the Expert Session - Zurich / Hamburg Interactive Cases
Moderators: K. H. Kuck, Hamburg and F. Duru, Zurich

Different ablation approaches in AF

15:30 Clinical case 1 A. Saguner, Zurich
15:45 Panel discussion and questions from the audience
15:55 Clinical case 2 T. Maurer, Hamburg
16:10 Panel discussion and questions from the audience
16:20 Take-home message K. H. Kuck, Hamburg
F. Duru, Zurich
Davos 2
16:30 – 17:30 Session 4: New ESC Guidelines and Position Papers
Chairs: J. J. Bax, Leiden and A. Vahanian, Paris
16:30 New ESC Guidelines on endocarditis G. Habib, Marseille
16:50 Do we need new guidelines in myocarditis? H. P. Schultheiss, Berlin
17:10 New ESC Position Paper on cancer treatments and cardiovascular toxicity T. Suter, Bern
Davos 1
16:30 – 17:30 Session 5: Pulmonary Hypertension
Chairs: F. J. Pinto, Lisbon and S. Ulrich Somaini, Zurich
16:30 Right ventricle and pulmonary vasculature – a functional unit? A. la Gerche, Melbourne
16:50 Pulmonary hemodynamics at exercise in PH – do’s and don’t’s? H. Olschewski, Graz
17:10 State of the art treatment on pulmonary hypertension – Guidelines versus individualized therapy E. Grünig, Heidelberg
17:30 – 17:45 Apéro Riche

only for participants of the satellite symposium

Davos 2
17:45 – 19:00 Satellite Symposium Biotronik
Chair: J. Steffel, Zurich

Modern management of cardiac device patients

17:45 Introduction J. Steffel, Zurich
17:50 Remote monitoring – current data and concepts for success F. Ruschitzka, Zurich
18:10 Optimal care for patients with cardioinhibitory vasovagal syncope M. Brignole, Lavagna
18:30 Revival of the VDD concept – from ICD to CRT-D J. Steffel, Zurich
18:50 Discussion and take-home message J. Steffel, Zurich
20:00 – 22:30 Official Dinner Hotel Morosani Schweizerhof